NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Augment Biologics

Augment Biologics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://agmt.bio/

Last Round

Accelerator

Sep 2, 2025

Total Funding Raised

$350,000

Company Overview

Augment Biologics is a biotechnology company that develops an AI-powered platform for site-specific glycoprotein engineering to enhance the efficacy, safety, and durability of biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

glycoprotein engineeringglycoengineeringAI drug designbiologic drug developmentprotein engineeringglycoprogrammingantibody engineeringin silico drug designbiotech platformAI for biologydrug discoveryprotein therapeuticsCDMOcontract developmentgenerative biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Augment Biologics Comparables

Compare Augment Biologics with similar companies based on industry and business-model similarity.

Augment Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kyron.bio
74%
AbInitio Bio
72%
EvolutionaryScale
71%

Augment Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 2, 2025
Pre SeedAug 13, 2025
AcceleratorDec 2, 2024

Augment Biologics Investors

Notable investors and investment history

Augment Biologics investors
InvestorRounds
Northpond VenturesAccelerator
McKesson VenturesAccelerator
IndieBioPre Seed
Merck Digital Sciences StudioAccelerator
New Jersey Innovation InstituteAccelerator
SOSVPre Seed

Augment Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Augment Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Augment Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2024
Last FundingSep 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.